Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel plus Aspirin in High-Risk TIA and Minor Ischemic Stroke
NCT00991029Phase 3Terminated
- Sponsor
- University of California, San Francisco
- Start
- May 2010
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of clopidogrel in Transient Ischemic Attack (TIA), ischemic stroke, sponsored by University of California, San Francisco. Started May 2010; status: terminated.
02
Drugs
clopidogrel
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT00991029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00991029.